- Ghana has seen disturbing increases in the active case count since the beginning of this year
- The country is expected to take delivery of some 17million doses of the vaccines by June
- It has been warned that the world can only return to normal times with a wide coverage of the vaccines
Our manifesto: This is what YEN.com.gh believes in
COVID-19 has killed seven more people in Ghana. This brings the country’s death toll to 440.
The country since the inception of this year witnessed an astronomical surge in active case count.
Active cases stand at 6,086 at the time of filing this report, following the recording of 697 new cases, according to the Ghana Health Service (GHS) website.
Seventy-eight thousand, five hundred and twenty-six Ghanaians have been infected by the virus since the confirmation of the first two cases in March.
Currently, there are 126 persons in severe condition, with 46 others in critical condition.
A member of the World Health Organisation’s (WHO) committee for COVID-19, Prof Helen Rees, warned that the world will only return to normal times well into 2022.
The South African, who is one of the world’s leading scientists, said normalcy would likely return after high coverage of the vaccines.
"I think this new normal we all talk about is with us for a very long time,” Rees told the BBC.
A herbal medicine, Cryptolepis sanguinolenta, was approved for a clinical trial in Ghana for the treatment of COVID-19.
Known locally as ‘Nibima’, Cryptolepis sanguinolenta's approval for the trial was announced on Monday, February 1, 2021, by the Food and Drugs Authority (FDA).
The herbal medicine developed by the School of Public Health at the Kwame Nkrumah University of Science and Technology (KNUST) was submitted to the FDA for the clinical trial in September 2020, and approval was granted in January 2021.
Meanwhile, Ghana is set to receive the first batch of over 17 million vaccines the country is expecting in March 2021.
The country has been earmarked as one of the 145 counties of the UN-led COVAX Facility to take delivery of 2.4 million doses of the AstraZeneca vaccine which is licensed to the Serum Institute of India (AZ/SII).
The delivery is estimated to begin before the end of February.
The vaccine is expected to be administered to persons in key sectors such as health workers in the first quarter.
Enjoy reading our stories?
Download YEN's news app on Google Play now and stay up-to-date with major Ghana news!